In 2014, the Turkish Constitutional Court hit the headlines after cancelling several articles of the Decree Law No. 556 on the Protection of... [Read More]
In Turkey, a process called an “abbreviated application” allows generic drug producers to apply for marketing authorization without submitting information about tests and... [Read More]
On 21 July 2015, a group of petitioners (“Petitioners”) asked the United States Department of Commerce (“DoC”) to initiate an anti-dumping investigation into... [Read More]
The following article gives a summary of decrees by the Council of Ministers and communiqués by the Ministry of Economy regarding prevention of... [Read More]
Undertakings in Turkey that are dominant in their market must be careful not to abuse this position, or their conduct may become scrutinised... [Read More]
Whistleblowing poses considerable risks for employers: as well as dealing with any corruption-related issues that they may pose, they need to be careful... [Read More]
Regulatory overview 1. What are the main legislation and regulatory authorities for pharmaceuticals in your jurisdiction? Legislation In this chapter, medicinal products... [Read More]
According to sector reports from local industry associations, Turkey’s information and communications technology, new media and e-commerce sectors are rapidly expanding.1 A joint report... [Read More]
The Turkish Constitutional Court (“Constitutional Court”) has struck out Article 7(1)(i) of the Trademark Decree Law numbered 556 (“Trademark Decree Law”), on the... [Read More]